MetaCap

Stablecoin Development (SDEV) vs Veru (VERU)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Veru (VERU) has outperformed Stablecoin Development (SDEV) over the past year, losing 12.6% versus a loss of 88.4%. Over five years, VERU leads with a -97.5% price change compared with -100.0% for SDEV. Stablecoin Development is the larger company by market cap ($36.9 million vs $33.1 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SDEV-88.37%VERU-12.61%
+2239%+1020%-199%
Nov 21, 20251 yearNov 20, 2026
SDEV-99.98%VERU-97.52%
+156%+22%-112%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SDEV versus VERU key metrics
MetricSDEVVERU
Share price$0.50$1.94
Market cap$36.90M$33.08M
1-day change-10.30%-8.06%
YTD return-98.23%-9.35%
1-year return-88.37%-12.61%
5-year return-99.98%-97.50%
P/E ratio (TTM)0.19—
EPS (TTM)$2.70$-0.61
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-630.78M$-22.73M
52-week high$99.75$7.33
52-week low$0.467$1.93
Distance from 52-week high-99.50%-73.53%
Analyst consensus—strong_buy
Avg. price target upside—+1223.20%
Average volume16.98M193.35K
Shares outstanding73.80M17.05M
Employees220
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • VERU has outperformed SDEV by 75.8 percentage points over the past year.

About Stablecoin Development

SDEV stock →

Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.

Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees

About Veru

VERU stock →

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.

Health Care · Biotechnology: Pharmaceutical Preparations · 20 employees

SDEV vs VERU FAQ

Which is bigger, Stablecoin Development or Veru?

Stablecoin Development (SDEV) is larger, with a market capitalization of $36.90M compared with $33.08M for Veru (VERU).

Which stock has performed better over the past year, SDEV or VERU?

VERU returned -12.61% over the past 12 months, compared with -88.37% for SDEV (price return, excluding dividends). Past performance does not predict future results.

Are Stablecoin Development and Veru in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons